Pre-Session Views

In today's views Strategy | Reiterating small-cap pharma call: Nile Pharma bubble crashed and Memphis Pharma will likely outperform in 2026MFPC roundtable takeaways | Structural export advantage reinforced, limited CBAM risk, and clear investment path ahead​CICH | 9M25 resilience underscores our EGP13/share fair valueTWSA | Preliminary indicators show promising growth in factoring